Title: FDA Grants Therapy Designation for Ocrelizumab in Primary Progressive MS
Description: FDA grants breakthrough therapy designation for the investigational medicine Ocrelizumab (OCREVUS) for treatment of primary progressive multiple sclerosis (PPMS).
URL: https://www.disabled-world.com/medical/clinical-trials/ocrelizumab.php
To see more Disabled World content in Google Search you can add us as a preferred source by clicking the above button, which will open a Google page, then check the box on the right of the page.